OneMedNet Corp Warrant (ONMDW) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ONMDW SEC filings page.
OneMedNet Corp Warrant (ONMDW) reported $1.5M in revenue over the twelve months to Jun 30, 2026, up 216.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
OneMedNet’s dominant mechanic is development-stage spending: expanding sales still sit beneath direct costs, R&D, and overhead, keeping operations cash-consuming.
Revenue more than doubled from$643K in FY2024 to$1.4M in FY2025, but the business remained loss-making at the gross-profit level; sales growth has not yet produced positive unit economics. Operating cash flow of-$7.5M nearly matched free cash flow of-$7.5M , so FY2025 cash use was driven overwhelmingly by operations rather than capital investment.
R&D exceeded FY2025 revenue, at
Liabilities were 2.4x total assets and the current ratio was 0.4x in FY2025, a combination that indicates negative equity and near-term obligations larger than near-term assets. The balance sheet therefore relies more on external financing than on accumulated asset backing.
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of OneMedNet Corp Warrant's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
OneMedNet Corp Warrant's reported operating margin for fiscal year 2025 is below the lowest share of revenue this page publishes, so the figure is not shown here. This dimension scores 19/100.
OneMedNet Corp Warrant's revenue surged 111.4% year-over-year to $1.4M, reflecting rapid business expansion. This strong growth earns a score of 76/100.
Not available for OneMedNet Corp Warrant, and counted as zero in the overall score.
OneMedNet Corp Warrant's current ratio of 0.43 is below the typical benchmark, resulting in a score of 3/100. This tight liquidity could limit financial flexibility if cash inflows slow.
OneMedNet Corp Warrant's reported free cash flow margin for fiscal year 2025 is below the lowest share of revenue this page publishes, so the figure is not shown here. This dimension scores 1/100.
Not available for OneMedNet Corp Warrant, and counted as zero in the overall score.
OneMedNet Corp Warrant passes 5 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
OneMedNet Corp Warrant reported a net loss of $2.8M while operations used $7.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.
OneMedNet Corp Warrant reported an operating loss of $9.7M against $67K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
OneMedNet Corp Warrant generated $292K in revenue in Q2 2026. This represents an increase of 88.4% from the same quarter a year earlier. Against the prior quarter it is up 204.2%.
OneMedNet Corp Warrant reported -$2.2M in net income in Q2 2026. This represents a decrease of 172.8% from the same quarter a year earlier. Against the prior quarter it is up 11.5%.
OneMedNet Corp Warrant earned -$0.04 per diluted share (EPS) in Q2 2026. This represents a decrease of 157.1% from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q2 2026.
Cash & Balance Sheet
OneMedNet Corp Warrant recorded an outflow of $1.9M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 14.1% from the same quarter a year earlier. Against the prior quarter it is down 22.0%.
OneMedNet Corp Warrant held $358K in cash against $132K in long-term debt as of Q2 2026, with $4.7M of liabilities due within a year.
Not reported for Q2 2026.
Margins & Returns
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q2 2026.
Capital Allocation
OneMedNet Corp Warrant invested $324K in research and development in Q2 2026. This represents a decrease of 15.2% from the same quarter a year earlier. Against the prior quarter it is up 4.2%.
OneMedNet Corp Warrant invested $9K in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 200.0% from the same quarter a year earlier. Against the prior quarter it is up 350.0%.
Not reported for Q2 2026.
ONMDW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-K | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-K | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $292K+88.4% | $96K-29.9% | $890K+3323.1% | $177K+24.6% | $155K-31.7% | $137K-44.8% | $26K-91.9% | $142K-56.4% |
| Cost of Revenue | $857K+116.4% | $476K+31.9% | $706K+1257.7% | $399K+76.5% | $396K+20.4% | $361K+13.9% | $52K-84.6% | $226K-22.9% |
| Gross Profit | -$565K-134.4% | -$380K-69.6% | $184K+807.7% | -$222K-164.3% | -$241K-136.3% | -$224K-224.6% | -$26K-62.5% | -$84K-354.5% |
| R&D Expenses | $324K-15.2% | $311K-10.6% | $462K+35.5% | $323K+8.4% | $382K-0.3% | $348K-21.8% | $341K-31.7% | $298K-26.4% |
| SG&A Expenses | $981K-17.1% | $1.5M+8.9% | $2.4M+14.4% | $1.4M-23.6% | $1.2M-31.1% | $1.4M+0.3% | $2.1M+100.1% | $1.8M+38.3% |
| Operating Income | -$2.3M-9.6% | -$2.6M-14.7% | -$3.1M-15.9% | -$2.2M+4.3% | -$2.1M+15.9% | -$2.2M-5.9% | -$2.7M | -$2.3M-21.2% |
| EBITDA | N/A | -$2.5M-14.9% | N/A | N/A | N/A | -$2.2M-5.8% | -$2.7M | -$2.3M-21.3% |
| Interest Expense | $9K-59.1% | $10K-67.7% | $8K-91.4% | $6K-57.1% | $22K+46.7% | $31K+24.0% | $93K | $14K |
| Net Income | -$2.2M-172.8% | -$2.5M-29.0% | -$3.1M-32.3% | -$741K+64.0% | $3.0M+183.1% | -$1.9M+9.8% | -$2.4M | -$2.1M+85.1% |
| EPS (Basic) | -$0.04-157.1% | -$0.04+33.3% | -$0.070.0% | -$0.01+85.7% | $0.07+150.0% | -$0.06+25.0% | -$0.07-103.6% | -$0.07+97.8% |
| EPS (Diluted) | -$0.04-157.1% | -$0.04 | -$0.070.0% | -$0.01 | $0.07 | -$0.06+25.0% | -$0.07-103.6% | -$0.07 |
| Diluted Shares (Avg) | 58M+51.1% | 55M | N/A | 53M | 38M | 34M+36.8% | N/A | 29M |
Not reported in any period shown, so not listed: Income Tax.
ONMDW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-K | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-K | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4M-41.6% | $1.5M-13.0% | $2.2M-42.3% | $1.5M-65.7% | $2.3M+124.5% | $1.7M+130.9% | $3.7M+703.2% | $4.4M+52.8% |
| Current Assets | $1.3M-42.1% | $1.5M-10.5% | $2.1M-42.1% | $1.4M-66.4% | $2.3M+137.1% | $1.6M+148.6% | $3.6M+891.5% | $4.3M+435.3% |
| Cash & Equivalents | $358K+193.4% | $233K+61.8% | $585K+240.1% | $149K-92.3% | $122K-70.0% | $144K-17.2% | $172K+266.0% | $1.9M+216.0% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $664K+161.4% | $697K+182.2% | $495K+132.4% | $582K+823.8% | $254K+238.7% | $247K-2.4% | $213K+40.1% | $63K-40.0% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.9M-21.0% | $5.6M-69.4% | $5.1M-74.0% | $5.4M-70.8% | $6.2M-69.5% | $18.3M+11.1% | $19.7M+41.5% | $18.7M-63.1% |
| Current Liabilities | $4.7M-23.3% | $5.4M-70.5% | $4.8M-74.9% | $5.0M-73.1% | $6.2M-69.3% | $18.2M+23.9% | $19.2M+39.0% | $18.6M-62.7% |
| Non-Current Liabilities | $156K+766.7% | $231K+80.5% | $291K-35.2% | $440K+1471.4% | $18K-90.1% | $128K-92.9% | $449K+560.3% | $28K-96.3% |
| Long-Term Debt | $132K | $176K-92.5% | $220K-90.5% | N/A | N/A | $2.3M | $2.3M+398.7% | $2.3M |
| Total Equity | -$3.5M+8.4% | -$4.1M+75.4% | -$3.0M+81.4% | -$3.9M+72.4% | -$3.8M+80.0% | -$16.6M-5.4% | -$15.9M-18.7% | -$14.3M+70.1% |
| Retained Earnings | -$109.0M-8.5% | -$106.8M-3.2% | -$104.4M-2.8% | -$101.2M-2.1% | -$100.5M-3.4% | -$103.5M-10.6% | -$101.6M-11.1% | -$99.2M-11.6% |
Not reported in any period shown, so not listed: Inventory, Goodwill.
ONMDW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-K | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-K | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.9M+14.3% | -$1.5M+16.8% | -$1.7M+14.2% | -$1.7M+8.2% | -$2.2M-45.4% | -$1.9M-19.8% | -$2.0M-15.7% | -$1.9M-73.0% |
| Depreciation & Amortization | N/A | $11K-8.3% | $9K-65.4% | N/A | N/A | $12K+9.1% | $26K+188.9% | $10K0.0% |
| Stock-Based Compensation | N/A | $431K+107.2% | N/A | $142K-31.4% | $197K+91.3% | $208K+51.8% | N/A | $207K-74.1% |
| Capital Expenditures | $9K+200.0% | $2K-60.0% | $5K-85.7% | $0-100.0% | $3K+200.0% | $5K-16.7% | $35K+118.8% | $9K-57.1% |
| Free Cash Flow | -$1.9M+14.1% | -$1.5M+16.9% | -$1.7M+15.4% | -$1.7M+8.6% | -$2.2M-45.5% | -$1.9M-19.7% | -$2.0M-16.7% | -$1.9M-70.6% |
| Investing Cash Flow | $56K+108.4% | $352K-81.7% | -$51K-114.0% | $1.1M+147.4% | -$670K-66900.0% | $1.9M+32100.0% | $365K+2381.3% | -$2.3M-11042.9% |
| Financing Cash Flow | $1.9M-31.5% | $838K+991.5% | $2.2M+1779.4% | $666K-87.8% | $2.8M+39.1% | -$94K-105.6% | -$131K-111.1% | $5.5M+284.9% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
ONMDW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-K | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-K | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -193.5% | -395.8% | 20.7%+120.7pp | -125.4% | -155.5% | -163.5% | -100.0%-95.0pp | -59.2%-69.3pp |
| Operating Margin | -774.3% | -2658.3% | -353.4% | -1262.7% | -1331.0% | -1623.4% | -10438.5% | -1645.1% |
| Net Margin | -743.8% | -2555.2% | -352.8% | -418.6% | 1923.9% | -1388.3% | -9126.9% | -1449.3% |
| Return on Assets | -159.2%-286.8pp | -162.8%-52.9pp | -146.0%-82.3pp | -49.2%-2.3pp | 127.6%+472.4pp | -109.8%+171.4pp | -63.7% | -46.9%+435.2pp |
| Current Ratio | 0.28-0.1x | 0.27+0.2x | 0.43+0.2x | 0.29+0.1x | 0.37+0.3x | 0.090.0x | 0.19+0.2x | 0.23+0.2x |
| Asset Turnover | 0.21+0.1x | 0.060.0x | 0.41+0.4x | 0.12+0.1x | 0.07-0.2x | 0.08-0.3x | 0.01-0.7x | 0.03-0.1x |
| FCF Margin | -645.2% | -1608.3% | -193.0% | -987.0% | -1414.2% | -1356.9% | -7811.5% | -1346.5% |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$3.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.43), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| OneMedNet Corp Warrant ONMDW | FY2025 | $1.4M | -$2.8M | N/A | N/A | 17/100 |
| Aclarion, Inc. Warrant ACONW | FY2025 | $76K | -$7.2M | N/A | N/A | — |
| CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock CCLDO | FY2025 | $120.5M | $11K | 0.0% | N/A | 46/100 |
| LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock LFMDP | FY2025 | $194.1M | -$11.2M | -5.8% | N/A | 41/100 |
| OneMedNet Corp ONMD | FY2025 | $1.4M | -$2.8M | N/A | $38.7M | 17/100 |
| Zhongchao Inc. ZCMD | FY2025 | $11.4M | -$6.3M | -55.5% | $7.1M | 33/100 |
Where OneMedNet Corp Warrant Ranks
Frequently Asked Questions
What is OneMedNet Corp Warrant's annual revenue?
OneMedNet Corp Warrant (ONMDW) reported $1.4M in total revenue for fiscal year 2025. This represents a 111.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is OneMedNet Corp Warrant's revenue growing?
OneMedNet Corp Warrant (ONMDW) revenue grew by 111.4% year-over-year, from $643K to $1.4M in fiscal year 2025.
Is OneMedNet Corp Warrant profitable?
No, OneMedNet Corp Warrant (ONMDW) reported a net income of -$2.8M in fiscal year 2025.
What is OneMedNet Corp Warrant's EBITDA?
OneMedNet Corp Warrant (ONMDW) had EBITDA of -$9.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does OneMedNet Corp Warrant have?
As of fiscal year 2025, OneMedNet Corp Warrant (ONMDW) had $585K in cash and equivalents against $220K in long-term debt.
What is OneMedNet Corp Warrant's gross margin?
OneMedNet Corp Warrant (ONMDW) had a gross margin of -37.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is OneMedNet Corp Warrant's free cash flow?
OneMedNet Corp Warrant (ONMDW) recorded an outflow of $7.5M in free cash flow during fiscal year 2025. This represents a -7.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is OneMedNet Corp Warrant's operating cash flow?
OneMedNet Corp Warrant (ONMDW) recorded an outflow of $7.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are OneMedNet Corp Warrant's total assets?
OneMedNet Corp Warrant (ONMDW) had $2.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What are OneMedNet Corp Warrant's capital expenditures?
OneMedNet Corp Warrant (ONMDW) invested $13K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does OneMedNet Corp Warrant spend on research and development?
OneMedNet Corp Warrant (ONMDW) invested $1.5M in research and development during fiscal year 2025.
What is OneMedNet Corp Warrant's current ratio?
OneMedNet Corp Warrant (ONMDW) had a current ratio of 0.43 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is OneMedNet Corp Warrant's return on assets (ROA)?
OneMedNet Corp Warrant (ONMDW) had a return on assets of -130.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does OneMedNet Corp Warrant's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, OneMedNet Corp Warrant (ONMDW) held $585K in cash, cash equivalents and investments, and reported an operating cash outflow of $7.5M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is OneMedNet Corp Warrant's debt-to-equity ratio negative or not reported?
OneMedNet Corp Warrant (ONMDW) has negative shareholder equity of -$3.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is OneMedNet Corp Warrant's Piotroski F-Score?
OneMedNet Corp Warrant (ONMDW) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are OneMedNet Corp Warrant's earnings high quality?
OneMedNet Corp Warrant (ONMDW) reported a net loss of $2.8M while operations used $7.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can OneMedNet Corp Warrant cover its interest payments?
OneMedNet Corp Warrant (ONMDW) reported an operating loss of $9.7M against $67K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is OneMedNet Corp Warrant?
OneMedNet Corp Warrant (ONMDW) scores 17 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.